Protective effects of metallothionein against dopamine quinone-induced dopaminergic neurotoxicity

FEBS Lett. 2007 Oct 16;581(25):5003-8. doi: 10.1016/j.febslet.2007.09.046. Epub 2007 Sep 29.

Abstract

Dopamine (DA) quinone as DA neuron-specific oxidative stress conjugates with cysteine residues in functional proteins to form quinoproteins. Here, we examined the effects of cysteine-rich metal-binding proteins, metallothionein (MT)-1 and -2, on DA quinone-induced neurotoxicity. MT quenched DA semiquinones in vitro. In dopaminergic cells, DA exposure increased quinoproteins and decreased cell viability; these were ameliorated by pretreatment with MT-inducer zinc. Repeated L-DOPA administration markedly elevated striatal quinoprotein levels and reduced the DA nerve terminals specifically on the lesioned side in MT-knockout parkinsonian mice, but not in wild-type mice. Our results suggested that intrinsic MT protects against L-DOPA-induced DA quinone neurotoxicity in parkinsonian mice by its quinone-quenching property.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line
  • Cytoprotection
  • Dopamine / analogs & derivatives*
  • Dopamine / chemistry
  • Dopamine / toxicity
  • Dopamine Agents / chemistry
  • Dopamine Agents / toxicity*
  • Levodopa / pharmacology
  • Metallothionein / genetics
  • Metallothionein / physiology*
  • Mice
  • Mice, Knockout
  • Oxidopamine / toxicity
  • Parkinson Disease, Secondary / chemically induced*
  • Parkinson Disease, Secondary / metabolism
  • RNA, Messenger / metabolism
  • Zinc / pharmacology

Substances

  • Dopamine Agents
  • Mt2 protein, mouse
  • RNA, Messenger
  • metallothionein-1, mouse
  • Levodopa
  • dopamine quinone
  • Oxidopamine
  • Metallothionein
  • Zinc
  • Dopamine